This study investigated the contribution of macrophage migration inhibitory factor (MIF) for the development of ventral prostate in pubertal and adult mice. Mice aged 30 or 60 days from C57BL/6 WT (wild-type) and MIF−/−(knockout) strains were studied. Histological analysis, immunohistochemistry (smooth muscle alpha-actin, vimentin, PCNA, WNT5a), serum testosterone, and western blotting for ERK1/2 were performed. Thirty-day-old MIF−/− mice exhibited higher testosterone serum levels, and the ventral prostate presented enlarged luminal area as well as decreased collagen and smooth muscle cell content. Regarding cell proliferation, there was an important reduction in MIF−/− mice of both ages. In addition, MIF−/− 30 mice presented elevated ERK activation and WNT5a scores in the prostate. This study showed that developmental change expected only at adulthood of prostate is already very evident at 30 days of age in MIF−/− mice, anticipating the pubertal development. Thus, MIF has a stimulative role in proliferation and also modulates androgenic stimuli in the prostate, which can contribute to gland development from puberty to adulthood.
IttmannM.Anatomy and histology of the human and murine prostate. Cold Spring Harb Perspect Med. 2018;8(5):a030346. doi:10.1101/cshperspect.a030346.
2.
FrancisJCSwainA.Prostate organogenesis. Cold Spring Harb Perspect Med. 2018;8(7):a030353. doi:10.1101/cshperspect.a030353.
3.
SugimuraYCunhaGRDonjacourAA.Morphogenesis of ductal networks in the mouse prostate. Biol Reprod. 1986;34(5):961–71. doi:10.1095/biolreprod34.5.961.
4.
VilamaiorPSTabogaSRCarvalhoHF.Postnatal growth of the ventral prostate in Wistar rats: a stereological and morphometrical study. Anat Rec A Discov Mol Cell Evol Biol. 2006;288(8):885–92. doi:10.1002/ar.a.20363.
5.
BuskinASinghPLorenzORobsonCStrandDWHeerR.A Review of prostate organogenesis and a role for iPSC-derived prostate organoids to study prostate development and disease. Int J Mol Sci. 2021;22(23):13097. doi:10.3390/ijms222313097.
6.
CunhaGRVezinaCMIsaacsonDTimmsBGCaoMFrancoOBaskinLS.Development of the human prostate. Differentiation. 2018;103:24–45. doi:10.1016/j.diff.2018.08.005.
7.
HaywardSWCunhaGR.The prostate: development and physiology. Radiol Clin North Am. 2000;38(1):1–14. doi:10.1016/s0033-8389(05)70146-9.
8.
CunhaGR.Epithelium-mesenchymal interactions in primordial gland structures which become responsive to androgenic stimulation. Anat Rec. 1972;172(2):179–95. doi:10.1002/ar.1091720206.
9.
CunhaGR.Mesenchymal-epithelial interactions: past, present, and future. Differentiation. 2008;76(6):578–86. doi:10.1111/j.1432-0436.2008.00290.x.
10.
RubinfeldHSegerR.The ERK cascade: a prototype of MAPK signaling. Mol Biotechnol. 2005;31(2):151–74. doi:10.1385/MB:31:2:151.
ZhangYZhangJLinYLanYLinCXuanJWShenMMMcKeehanWLGreenbergNMWangF.Role of epithelial cell fibroblast growth factor receptor substrate 2alpha in prostate development, regeneration and tumorigenesis. Development. 2008;135(4):775–84. doi:10.1242/dev.009910.
13.
PengLYeLDongGRenLBWangCLXuPZhouXD.WNT5A inhibits human dental papilla cell proliferation and migration. Biochem Biophys Res Commun. 2009;390(3):1072–8. doi:10.1016/j.bbrc.2009.10.136.
14.
ChengRSunBLiuZZhaoXQiLLiYGuQ.Wnt5a suppresses colon cancer by inhibiting cell proliferation and epithelial-mesenchymal transition. J Cell Physiol. 2014;229(12):1908–7. doi:10.1002/jcp.24566.
15.
YangJCusimanoAMongaJKPreziosiMEPullaraFCaleroGLangRYamaguchiTPNejak-BowenKNMongaSP.WNT5A inhibits hepatocyte proliferation and concludes β-catenin signaling in liver regeneration. Am J Pathol. 2015;185(8):2194–205. doi:10.1016/j.ajpath.2015.04.021.
HuangLPuYHuWYBirchLLuccio-CameloDYamaguchiTPrinsGS.The role of Wnt5a in prostate gland development. Dev Biol. 2009;328(2):188–99. doi:10.1016/j.ydbio.2009.01.003.
18.
Bruni-CardosoACarvalhoHF.Dynamics of the epithelium during canalization of the rat ventral prostate. Anat Rec (Hoboken). 2007;290(10):1223–32. doi:10.1002/ar.20591.
19.
AnaharaRToyamaYKodaMHonmaSNishihiraJToshimoriKMoriC.Deletion of macrophage migration inhibitory factor gene induces down regulation of sex hormones and ultrastructural abnormalities in mouse testes. Reprod Toxicol. 2006;21(2):167–70. doi:10.1016/j.reprotox.2005.08.001.
20.
CaltabianoRDe PasqualeRPiombinoECampoGNicolettiFCavalliEManganoKFagoneP.Macrophage Migration Inhibitory Factor (MIF) and its homologue d-Dopachrome Tautomerase (DDT) inversely correlate with inflammation in discoid lupus erythematosus. Molecules. 2021 Jan 1;26(1):184. doi:10.3390/molecules26010184.
21.
PenticuffJCWoolbrightBLSieleckiTMWeirSJTaylorJA3rd. MIF family proteins in genitourinary cancer: tumorigenic roles and therapeutic potential. Nat Rev Urol. 2019;16(5):318–28. doi:10.1038/s41585-019-0171-9.
22.
JankauskasSSWongDWLBucalaRDjudjajSBoorP.Evolving complexity of MIF signaling. Cell Signal. 2019;57:76–88. doi:10.1016/j.cellsig.2019.01.006.
23.
NobreCCde AraújoJMFernandesTACobucciRNLanzaDCAndradeVSFernandesJV.Macrophage Migration Inhibitory Factor (MIF): biological activities and relation with cancer. Pathol Oncol Res. 2017;23(2):235–44. doi:10.1007/s12253-016-0138-6.
24.
SumaiyaKLangfordDNatarajaseenivasanKShanmughapriyaS.Macrophage Migration Inhibitory Factor (MIF): a multifaceted cytokine regulated by genetic and physiological strategies. Pharmacol Ther. 2022;233:108024. doi:10.1016/j.pharmthera.2021.108024.
25.
BloomBRBennettB.Mechanism of a reaction in vitro associated with delayed-type hypersensitivity. Science. 1966;153(3731):80–2. doi:10.1126/science.153.3731.80.
26.
MerkMMitchellRAEndresSBucalaR.D-dopachrome tautomerase (D-DT or MIF-2): doubling the MIF cytokine family. Cytokine. 2012;59(1):10–7. doi:10.1016/j.cyto.2012.03.014.
27.
Meyer-SieglerKFattorRAHudsonPB.Expression of macrophage migration inhibitory factor in the human prostate. Diagn Mol Pathol. 1998;7(1):44–50. doi:10.1097/00019606-199802000-00008.
28.
Meyer-SieglerKLIczkowskiKAVeraPL.Further evidence for increased macrophage migration inhibitory factor expression in prostate cancer. BMC Cancer. 2005;5:73. doi:10.1186/1471-2407-5-73.
29.
BozzaMSatoskarARLinGLuBHumblesAAGerardCDavidJR.Targeted disruption of migration inhibitory factor gene reveals its critical role in sepsis. J Exp Med. 1999;189:341–6. doi:10.1084/jem.189.2.341.
30.
WeibelER.Selection of the best method in stereology. J Microsc. 1974;100(3):261–9. doi:10.1111/j.1365-2818.1974.tb03938.x.
31.
RamosRFOshimaCTFGomesTSMaderAMAAAlvesCDMWaisbergJ.Immunohistochemical study of the canonical and non-canonical Wnt signaling pathway in colorectal carcinoma and non-neoplastic mucosa. J Coloproctol. 2015;35(3):156–61. doi:10.1016/j.jcol.2015.06.002.
32.
BradfordMM.A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72(1–2):248–54.
33.
Serre-BeinierVTosoCMorelPGonelle-GispertCVeyrat-DurebexCRohner-JeanrenaudFCalandraTRogerTJamesRWMontetXBühlerLBoscoDBerneyT.Macrophage migration inhibitory factor deficiency leads to age-dependent impairment of glucose homeostasis in mice. J Endocrinol. 2010;206(3):297–306. doi:10.1677/JOE-09-0342.
Morales-MontorJBaigSKabbaniADamianRT.Do interleukin-6 and macrophage-migration inhibitory factor play a role during sex-associated susceptibility in murine cysticercosis. Parasitol Res. 2002 Oct;88(10):901–4. doi:10.1007/s00436-002-0674-8.
36.
CunhaGRDonjacourAACookePSMeeSBigsbyRMHigginsSJSugimuraY.The endocrinology and developmental biology of the prostate. Endocr Rev. 1987;8(3):338–62. doi:10.1210/edrv-8-3-338.
37.
MillsJSNeedhamMThompsonTCParkerMG.Androgen-regulated expression of secretory protein synthesis in mouse ventral prostate. Mol Cell Endocrinol. 1987;53(1–2):111–8. doi:10.1016/0303-7207(87)90197-3.
38.
RichardsZMcCrayTMarsiliJZennerMLManlucuJTGarciaJKajdacsy-BallaAMurrayMVoisineCMurphyABAbdulkadirSAPrinsGSNonnL.Prostate stroma increases the viability and maintains the branching phenotype of human prostate organoids. iScience. 2019;12:304–17. doi:10.1016/j.isci.2019.01.028.
39.
ThomsonAACunhaGRMarkerPC.Prostate development and pathogenesis. Differentiation. 2008;76(6):559–64. doi:10.1111/j.1432-0436.2008.00303.x.
40.
TabogaSRVilamaiorPSLGóesRM.Modulação androgênica e estrogênica na próstata: uma abordagem em modelos experimentais de roedores com enfoque na biologia estrutural. Arq Bras Endocrinol & Metab. 2009;53(8):946–55. doi:10.1590/S0004-27302009000800007.
41.
ZhangBShenMXuMLiuLLLuoYXuDQWangYXLiuMLLiuYDongHYZhaoPTLiZC.Role of macrophage migration inhibitory factor in the proliferation of smooth muscle cell in pulmonary hypertension. Mediators Inflamm. 2012;2012:840737. doi:10.1155/2012/840737.
42.
FanYZhangJChenCYXiaoYBAsicoLDJosePAXuJCQianGSZengCY.Macrophage migration inhibitory factor triggers vascular smooth muscle cell dedifferentiation by a p68-serum response factor axis. Cardiovasc Res. 2017;113(5):519–30. doi:10.1093/cvr/cvx025.
43.
OwenJSClaytonAPearsonHB.Cancer-associated fibroblast heterogeneity, activation and function: implications for prostate cancer. Biomolecules. 2022;13(1):67. doi:10.3390/biom13010067.
44.
Di CarloESorrentinoC. The multifaceted role of the stroma in the healthy prostate and prostate cancer. J Transl Med. 2024;22(1):825. doi:10.1186/s12967-024-05564-2.
45.
NingyanGXuYHongfeiSJingjingCMinC.The role of macrophage migration inhibitory factor in mast cell-stimulated fibroblast proliferation and collagen production. PLoS ONE. 2015;10(3):e0122482. doi:10.1371/journal.pone.0122482.
46.
LuoYYiHHuangXLinGKuangYGuoYXieC.Inhibition of macrophage migration inhibitory factor (MIF) as a therapeutic target in bleomycin-induced pulmonary fibrosis rats. Am J Physiol Lung Cell Mol Physiol. 2021;321(1):L6–16. doi:10.1152/ajplung.00288.2020.
47.
KindtNJourneFLaurentGSaussezS.Involvement of macrophage migration inhibitory factor in cancer and novel therapeutic targets. Oncol Lett. 2016;12(4):2247–53. doi:10.3892/ol.2016.4929.
48.
NoeJTMitchellRA.MIF-dependent control of tumor immunity. Front Immunol. 2020;11:609948. doi:10.3389/fimmu.2020.609948.
49.
WirtzTHSaalABergmannIFischerPHeinrichsDBrandtEFKoenenMTDjudjajSSchneiderKMBoorPBucalaRWeiskirchenRBernhagenJTrautweinCBerresML.Macrophage migration inhibitory factor exerts pro-proliferative and anti-apoptotic effects via CD74 in murine hepatocellular carcinoma. Br J Pharmacol. 2021;178(22):4452–67. doi:10.1111/bph.15622.
50.
CharanMDasSMishraSChatterjeeNVarikutiSKaulKMisriSAhirwarDKSatoskarARGanjuRK.Macrophage migration inhibitory factor inhibition as a novel therapeutic approach against triple-negative breast cancer. Cell Death Dis. 2020;11(9):774. doi:10.1038/s41419-020-02992-y.
RosatiRPatkiMChariVDakshnamurthySMcFallTSaxtonJKidderBLShawPERatnamM.The amino-terminal domain of the androgen receptor co-opts Extracellular Signal-regulated Kinase (ERK) docking sites in ELK1 protein to induce sustained gene activation that supports prostate cancer cell growth. J Biol Chem. 2016Dec9;291(50):25983–98. doi:10.1074/jbc.M116.745596.
PeterzielHMinkSSchonertABeckerMKlockerHCatoAC.Rapid signalling by androgen receptor in prostate cancer cells. Oncogene. 1999Nov4;18(46):6322–9. doi:10.1038/sj.onc.1203032.
55.
FixCJordanCCanoPWalkerWH.Testosterone activates mitogen-activated protein kinase and the cAMP response element binding protein transcription factor in Sertoli cells. Proc Natl Acad Sci U S A. 2004Jul27;101(30):10919–24. doi:10.1073/pnas.0404278101.
56.
PakulaHXiangDLiZ.A tale of two signals: AR and WNT in development and tumorigenesis of prostate and mammary gland. Cancers (Basel). 2017;9(2):14. doi:10.3390/cancers9020014.
57.
PakSParkSKimYParkJHParkCHLeeKJKimCSAhnH.The small molecule WNT/β-catenin inhibitor CWP232291 blocks the growth of castration-resistant prostate cancer by activating the endoplasmic reticulum stress pathway. J Exp Clin Cancer Res. 2019;38(1):440. doi:10.1186/s13046-019-1451-1.
58.
ThieleSGöbelARachnerTDFuesselSFroehnerMMudersMHBarettonGBBernhardtRJakobFGlüerCCBornhäuserMRaunerMHofbauerLC.WNT5A has anti-prostate cancer effects in vitro and reduces tumor growth in the skeleton in vivo. J Bone Miner Res. 2015;30(3):471–80. doi:10.1002/jbmr.2362.
59.
CassimiroISCruzARBosqueBPde Melo GomesLCZanonRGda Costa SilvaJRFujimuraPTUeira-VieiraCRibeiroDL.Rat postnatal prostate development is impaired by in vitro high-glucose environment. Reproduction. 2020;160(3):469–80. doi:10.1530/REP-20-0091.
